“Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 1, Jan. 2021, p. s5, https://doi.org/10.25251/skin.5.supp.5.